Dublin, County Dublin, Ireland, December 2025 — Health Products Regulatory Authority (HPRA) has announced the appointment of Grainne Power as Chief Executive, with effect from 1 January 2026. Ms Power brings significant experience from across the health products sector and has consistently demonstrated a strong commitment to both public and animal health.
Ms Power is currently Director of Compliance at the Health Products Regulatory Authority (HPRA), where she is responsible for an extensive range of licensing, inspection, market surveillance and enforcement activities relating to medicinal products, blood, tissues and cells, controlled substances and cosmetics.
Prior to that, she held the position of Director of Human Products Authorisation and Registration, where she was responsible for overseeing the assessment of authorisation applications for medicines and clinical trials.
As Chief Executive, Ms Power will lead the Health Products Regulatory Authority (HPRA) in its mission to protect and enhance human and animal health through the regulation of health products. Her leadership will also steer the organisation’s strategic ambitions, beginning with the imminent launch of its new 2026–2028 corporate strategy.
She succeeds Dr Lorraine Nolan, whose tenure as Chief Executive is concluding at the end of this year.
Grainne Power brings deep leadership across quality, regulatory, and health products governance shaped by significant experience beyond her current senior responsibilities at Health Products Regulatory Authority (HPRA).
Before joining HPRA, she served for around three years as Senior Director, Quality Assurance at Alexion Pharmaceuticals, Inc., contributing to high standards of pharmaceutical quality and compliance within a global biopharmaceutical environment.
She also spent over a decade working independently in Quality Management as a consultant and ‘Qualified Person’, supporting organisations with quality system development, interim leadership, and regulated operational oversight across the health products sector.
Earlier, she held the role of Quality Manager at Wyeth Medica for about three years, strengthening quality systems within a complex manufacturing context.
In the formative years of her career, she built strong foundations in regulated quality roles at Boston Scientific and Fort Dodge Animal Health, developing expertise that spans both human and animal health—an alignment that strongly fits HPRA’s dual public and veterinary remit.
About Health Products Regulatory Authority (HPRA)
Health Products Regulatory Authority (HPRA) regulates medicines and devices for the benefit of people and animals. Its remit and regulatory functions include human and veterinary medicines, clinical trials, medical devices, controlled drugs, blood and blood components, tissues and cells, and cosmetic products.
The Health Products Regulatory Authority (HPRA) is committed to excellence in health product regulation through science, collaboration and innovation, playing a central role in protecting and enhancing public and animal health in Ireland.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
